Control of fibroblast senescence and activation of programmed cell death

✍ Scribed by Dr. Eugenia Wang; Menq-Jer Lee; Siyaram Pandey

• Publisher: John Wiley and Sons
• Year: 1994
• Tongue: English
• Weight: 695 KB
• Volume: 54
• Category: Article
• ISSN: 0730-2312
• DOI: 10.1002/jcb.240540410

✦ Synopsis

Abstract

We have characterized a nuclear phosphoprotein of 57 kda, statin, found only in nonproliferating cells of both quiescent and senescent natures. Emerging results suggest that statin may function as a sequester to block the early G~1~ phase phosphorylation for the RB protein. A second protein, terminin, undergoes senescence‐specific posttranslational modification from 90 to 60 kda, and further death‐specific conversion from 60 to 30 kda. We also found that apoptotic mouse 3T3 fibroblasts express c‐fos, c‐myc, c‐jun, and cdc2, as well as the upregulation of RB phosphorylation and BrdU incorporation, just before final DNA fragmentation and death. It seems that en route to death, cells re‐enter the cell‐cycle traverse and experience early G~1~ and part of S Phase; however, this cycling event is an abortive one. In contrast, senescent fibroblasts are resistant to the initiation of the death program, since they are unable to enter cell cycle traverse. Long‐term serial passaging of normal human fibroblasts may be inadvertently selecting those, while termed as senescent, are also specialized survivors, and thus a good culture model to study both the control of permanent departure from cell cycle traverse and the mechanism underlying the survival or antideath cellular program.